Podcasts about Approved

5-for-5 is here, and the landscape of college wrestling is changed forever.TIMESTAMPS:0:00 - We're Back!03:45 - 5 for 5 is Here06:50 - Will Bo Bassett Get 5 Years?24:30 - A New Transfer Portal Window?34:25 - USA Gets 3rd Now35:15 - RAF 43:00 - India Age Cheating47:40 - Bo Bassett Live UpdateRokfin.com/MatScouts for all of Willie's Content!Be sure to SUBSCRIBE to the podcast. NEW EPISODES WEEKLY! Support the show & leave a 5-star rating and review on Apple Podcasts, and shop some apparel on BASCHAMANIA.com! For all partnership and sponsorship inquiries, email info@baschamania.com.BASCHAMANIA is a Basch Solutions Production. Learn more about Basch Solutions, a digital marketing agency specializing in custom websites, content creation, and digital strategy, at BaschSolutions.com.

Mark Hamilton sits down to talk about the latest news in the world of F1 and preview the Austrian Grand Prix. Hit that subscribe button and tune in for the full, unfiltered breakdown! Subscribe to the Scuderia F1 Podcast wherever you get your podcasts. Please leave us a rating and review if you enjoyed the show! Thanks for tuning in! Learn more about your ad choices. Visit megaphone.fm/adchoices

See omnystudio.com/listener for privacy information.

It's Monday, June 22. Here are today's top stories around Central Indiana. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org and follow us on social media to get local news every day. WFYI News Now is hosted by Barb Anguiano and produced by Zach Bundy. Subscribe wherever you get your podcasts.

It's Friday, June 19th, A.D. 2026. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Adam McManus Chinese police raid church during Sunday worship On June 14th, Communist authorities in southwestern China launched a large-scale raid against Early Rain Covenant Church at 11:00am during its Sunday worship service. They detained dozens of believers, reports ChinaAid. The church's worship service, which included families and children, was being held in a hotel conference room in Jiangyou City. The raid was conducted by 65 Communists including police officers, SWAT personnel, Domestic Security Protection Unit officers, religious affairs officials, and local government reps. They “stormed the venue and forcibly took control of the gathering." Church leaders said 33 believers were detained during the operation, including two elders, Yan Hong and Wu Wuqing. Please pray for the detained elders and frightened children and that their faith would overcome their fear. Psalm 27:3 says, “Though an army encamps against me, my heart shall not fear.” Vance To Israel: "Wake up" if you think Trump is your biggest problem On June 12th, President Donald Trump called Israeli Prime Minister Benjamin Netanyahu with news he did not want to hear: Trump expected to sign a deal with Iran within days, reported Axios. Trump said, "This is the deal. It's a great deal, and it's time to end this war.” Four months out from an election, Netanyahu's rivals are accusing him of making Israel a "vassal state" by simply accepting Trump's terms for peace. Asked about rumblings from Netanyahu's advisors about the US-Iran peace deal, Vice President J.D. Vance spoke directly on June 18th in the White House Briefing Room, reports RealClearPolitics.com. VANCE: “You have seen people within Bibi's cabinet who have come out and attacked the deal, and in some ways very personally attacked the President of the United States. My message to them would be two-fold. “Number one: Donald J. Trump is the only head of state in the entire world who is sympathetic to the nation of Israel at this moment in time. And he happens to be the head of state of the world's superpower. If I was in the cabinet of the Israeli government, I might not be attacking the only powerful ally that I have anywhere left in the entire world. “The second message I would give to some of those cabinet members in Israel, who are attacking the President of the United States, is that over the last three months, two-thirds of the defensive weapons that have protected your homeland have been built by American hands and paid for by American tax dollars. “The problem for Israel is not Donald J. Trump!  Anybody in Israel who thinks their biggest problem is the President of the United States needs to wake up and smell the reality of the situation that country is in. Bibi, to his credit, has not gone down this path.” California town initially approved drag queen at kids playground And finally, Christians in Oakdale, California were livid. And with good reason. The foolish Oakdale City Council, in this city of 24,000 people 100 miles outside San Francisco, initially approved a drag queen to emcee and entertain at a homosexual/transgender “pride” event to be held at Dorada children's park, playground, and swimming pool. It was set to take place on the Lord's Day, Sunday, June 28th between 10:00am and 2:00pm -- complete with yard games, face painting, and food. Pastor Jeff Cavanaugh of Calvary Chapel Oakdale was interviewed by the local ABC affiliate. CAVANAUGH: “We wouldn't have children in a strip club, and to me it's just very similar to that. I just don't think children should be exposed to that.” And Dan Phipps, an elder at Mountain View Church in Oakdale, alerted his congregation during the service. PHIPPS: “They're seeking to hold a ‘pride' event involving adult preferences for sexuality at a kids park. But it gets worse than that. This adult event, at a children's park, is scheduled to have a drag performer as entertainment. This drag performer publicly posts what most would consider explicit content on their social media accounts publicly for everybody to see their intentions. “To me, it couldn't be more clear. They're targeting our kids. They're planning on exposing children to the perversions and brokenness of this world, and they're parading sinful lifestyles before young and impressionable minds here in Oakdale.” Phipps urged the congregation to attend the June 15th Oakdale City Council meeting to speak out. PHIPPS: “Obviously, we're concerned about this. We want to invite you guys to join the [Mountain View Church] leadership at this event, attending the meeting. Demonstrate that there are many people in Oakdale who do not want these types of events promoted to children, seeking to attract children into a lifestyle that is contrary to God and His design.” The drag queen, who goes by the stage name “Sasha Devaroe,” is David Allen Soria Jr., a homosexual man who is faux married to another man named Larry. He was also interviewed by the Oakdale ABC affiliate. SORIA: “It's fear mongering. It's trying to put us back in the closet.” Soria thought having such an event in Oakdale was important. SORIA: “A small city like Oakdale can have something like this for community members who may be can't make it to San Francisco.” Sadly, despite the fact that hundreds of citizens showed up, including many Christians, the Oakdale City Council limited the number of speakers to just ten people. Listen to the comments from one of the Christians. CHRISTIAN MAN #1: “These predators are no longer satisfied behind closed doors, but demand their sexual perversions be consumed and normalized here in Oakdale. Notice where they want to hold this sexual event: in public, at our most popular children's park, next to the plunge pool, active with kids. “Keep in mind, this movement is responsible for the sterilization and mutilation of children, and is now openly targeting ours. They advertise on social media their groomers' desire to hug, play games with, and face paint girls and boys at the park. “The heritage of our town is under attack, and the very heart and soul of our Cowboy Capital of the World is at stake. We call upon you, our elected representatives, to uphold the traditions of conservative, family-friendly Oakdale that our cattlemen established.” (You can watch that section of the Oakdale City Council between 9:18 and 44:36 in this video). The final citizen at the podium did not pull any punches. CHRISTIAN MAN #2: “I just want to let you know that everybody here will stand at the throne [of God] and give an account for what they have and haven't done.” Romans 14:12 says, "So then, each of us will give an account of ourselves to God." To their credit, on June 18th, the Oakdale City Council announced a venue change from the public kids' park to an indoor, taxpayer-funded venue known as the Bianchi Community Center. You can send a thank you note to Oakdale Mayor Cherilyn Bairos at cbairos@oakdaleca.gov, telling her you appreciate the venue change which will better protect innocent children. The address is 280 N. Third Avenue, Oakdale, CA 95361. Close And that's The Worldview on this Friday, June 19th, in the year of our Lord 2026. Subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  Plus, you can get the Generations app through Google Play or The App Store. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

Cristina Gomez reviews the latest UFO / UAP news and covers a newly surfaced Pentagon UAP Tiger Team document, claims that UFO whistleblowers are being cleared on what they reveal, the Vice President admitting he still has not read the UFO files, and a strange new UFO claim from a famous actor.To see the VIDEO of this episode, click or copy link - https://youtu.be/Df0vKj4WFBYVisit my website with International UFO News, Articles, Videos, and Podcast direct links -www.ufonews.co00:00 - The UFO Claim00:31 - UFO Tiger Team Exposed03:36 - Cleared To Speak On UFOs04:36 - Underground UFO Programs06:02 - UFO Craft Already Approved06:43 - UFO Truth On A Leash07:57 - VP And The UFO Files10:12 - Actor's UFO Garage Claim Become a supporter of this podcast: https://www.spreaker.com/podcast/strange-and-unexplained--5235662/support.

Interview with Andrew Dennan, CEO of Halo MineralsRecording date: 16th June 2026Halo Minerals has emerged as a unique opportunity within the junior mining sector by focusing on the reprocessing of historical mine tailings rather than pursuing conventional greenfield mine development. Its flagship Playa Verde Project in Chile aims to recover copper and gold from legacy tailings deposits while simultaneously addressing a long-standing environmental liability.The company's most important achievement to date is securing approval of the project's Environmental Impact Assessment (EIA). For mining projects in Chile, permitting is often one of the largest barriers to development, creating uncertainty around timelines and project viability. With the EIA approved and formal written resolution received, Halo has substantially reduced a key project risk and can now focus on financing, engineering, and execution.The economics outlined in the recently published Competent Person's Report are compelling. The Playa Verde Project contains ore reserves of 32.2 million tonnes grading 0.25% copper, representing approximately 80,000 tonnes of contained copper. Using assumptions of US$5.30 per pound copper and US$4,300 per ounce gold, the project generates a post-tax NPV10 of approximately US$154 million and an estimated IRR of around 51%. These metrics compare favorably with the company's current valuation and suggest meaningful leverage to successful project development.Importantly, Halo is not relying on experimental technology. Management intends to utilize well-established dredging, flotation, and SX-EW processing methods that have been deployed successfully across the mining industry for decades. This reduces technical uncertainty and may improve financing prospects compared with projects dependent on novel extraction technologies.The broader copper market also provides supportive macroeconomic conditions. Demand continues to rise due to electrification, electric vehicle adoption, renewable energy infrastructure, and the expansion of AI-related data centres. At the same time, many industry analysts forecast structural supply deficits over the coming decade as permitting challenges and capital intensity limit the pace of new mine development. Tailings reprocessing projects such as Playa Verde offer a potentially faster route to supplying additional copper to the market.Another notable aspect of the investment case is management's financing strategy. Rather than relying heavily on equity issuance, Halo intends to pursue a combination of offtake agreements, vendor financing, royalty and streaming transactions, and project debt. If successfully executed, this approach could reduce shareholder dilution relative to many junior mining peers.Investors should nevertheless recognize the risks. The company remains pre-FID and must still secure financing and operating partners. Playa Verde currently represents the primary source of near-term value, creating concentration risk. Commodity price volatility, financing market conditions, and execution challenges could all affect outcomes.Looking ahead, the most important catalysts include completion of the updated feasibility study, finalization of financing arrangements, selection of operating partners, and progress toward a final investment decision targeted for late 2026. Success on these fronts would move Halo closer to its goal of first production in 2028 and provide a clearer indication of whether the project's attractive economics can be translated into shareholder value.Learn more: https://cruxinvestor.comSign up for Crux Investor: https://cruxinvestor.com

In this week's Focus Check, Nino and Johnnie tackle an industry in a tumultuous, consolidation-heavy phase. They open with the escalating Insta360 vs. DJI patent war over the Luna Ultra, then move through Artlist's layoffs, the US approval of Paramount's Warner Bros. merger, and MRMC's surprise liquidation just weeks after Nikon sold it off. From there the episode shifts into new gear: the budget Blazar Sentinel anamorphic zoom, the large-format Angénieux EZ 65 cine zooms, the Hollyland Astra P1 PTZ camera, the DJI Lito 1 drone, the SKYROVER S1 and X1 combos, Godox's inflatable lights, Tilta's foldable charger, plus deep dives on self-made virtual production and shooting a rocket launch in Apple Immersive Video. (00:00) Intro   (05:35) DJI sues Insta360, and Insta360 countersues DJI over Luna Ultra patent war https://www.cined.com/dji-sues-insta360-over-luna-cameras-seeking-a-u-s-sales-ban-on-launch-day/  https://www.cined.com/insta360-countersues-dji-over-luna-ultra-patent-war-asserting-five-u-s-patents/   (35:57) Artlist lays off 200 employees a year after hiring 120 https://www.cined.com/a-year-after-hiring-120-people-artlist-lays-off-200-employees/   (45:45) Paramount's $111 billion Warner Bros. merger wins US approval https://www.cined.com/paramounts-111-billion-warner-bros-merger-wins-us-approval-but-the-fight-is-far-from-over/   (48:25) MRMC enters liquidation weeks after Nikon exit https://www.cined.com/mrmc-enters-liquidation-weeks-after-nikon-exit-with-asset-sale-agreed-but-not-yet-closed/   (51:28) Blazar Sentinel anamorphic zoom announced https://www.cined.com/blazar-sentinel-anamorphic-zoom-announced-35-60mm-1-33x-squeeze-full-frame-coverage-970g/   (56:44) Angénieux EZ 65 series announced https://www.cined.com/angenieux-ez-65-series-announced-two-large-format-zooms-60mm-image-circle-lpl-mount/   (59:31) Hollyland Astra P1 PTZ camera announced https://www.cined.com/hollyland-astra-p1-ptz-camera-announced-uhd-4k60-30x-optical-zoom-ai-auto-tracking-and-more/   (1:03:12) DJI Lito 1 review https://www.cined.com/dji-lito-1-review-entry-level-drone-with-4k100-and-omnidirectional-vision/   (1:08:44) SKYROVER S1 and X1 Fly More combos add a touchscreen remote https://www.cined.com/skyrover-s1-and-x1-fly-more-combos-add-a-new-touchscreen-remote-with-5-5-inch-display/   (1:15:32) Godox LR150 Air and LC500R Air released https://www.cined.com/godox-lr150-air-and-lc500r-air-released-inflatable-ring-and-wand-heads-one-battery-grip-92-minute-runtime/   (1:19:30) Tilta foldable charging station introduced https://www.cined.com/tilta-foldable-charging-station-introduced-6-channel-np-f-charging-priority-fast-charge-mode-tft-status-display/   (1:22:49) Self-made virtual production – what do you need to get started? https://www.cined.com/self-made-virtual-production-what-do-you-need-to-get-started/   (1:24:53) Shooting a rocket launch in Apple Immersive Video https://www.cined.com/shooting-a-rocket-launch-in-apple-immersive-video-with-the-ursa-cine-immersive/

Well-designed rotation experiences are essential to developing competent and confident student pharmacists and residents. This course discusses how to structure rotations, align with institutional expectations, and create meaningful schedules, activities, and deliverables that balance service and learning, while introducing principles of deliberate practice to support ongoing skill development. You will gain practical strategies for designing engaging, well-organized, high-impact experiential learning experiences  HostKate Newman PharmD,Director of Experiential EducationClinical Associate Professor, Pharmacy PracticeSouthern Illinois University - EdwardsvilleGuestMayank Amin, PharmD, RPH, MBAPharmacistOwner, Skippack Pharmacy Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE Information Learning ObjectivesAt the end of this course, preceptors will be able to:1.  Describe key elements of effective rotation design, including structure, expectations, and learning activities. 2. Identify strategies to create engaging and high-impact rotation experiences for pharmacy learners. 0.1 CEU/1.0 HrUAN: 0107-0000-26-246-H99-PInitial release date: 6/17/2026Expiration date: 6/17/2029Additional CPE details can be found here.The speakers have no relevant financial relationships with ineligible companies to disclose.The examples shared in this episode are intended to illustrate approaches to experiential learning, service development, and patient care innovation and are not endorsements of any specific service, product, or practice model. Certain examples discussed may no longer be viable, appropriate, or permissible under current regulatory requirements. Pharmacists should exercise professional judgment and ensure compliance with applicable laws, regulations, payer requirements, and evidence-based standards when evaluating or implementing patient care services.This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Follow CEimpact on Social Media:LinkedInInstagram

Deepfakes, AI-generated documents, and machine-assisted analysis are arriving in courtrooms faster than the rules of evidence can adapt. Judge Paul Grimm joins TalksOnLaw to discuss how courts should authenticate and evaluate AI-generated evidence — and what judges and litigators can do now to prepare.How to Earn CLE CreditMCLE certificates are eligible only for TalksOnLaw Premium or Podcast members. To earn credit, listen to the full program, note the verification code announced during the recording, then log in to your TalksOnLaw account to record attendance and download your certificate at www.TalksOnLaw.com/podcast.Approved for 1 hr of general credit (Illinois) at the time of publication. Please visit TalksOnLaw to check whether older courses remain active for MCLE reporting purposes.

It's In The News - a look at the top diabetes stories and headlines happening now!   Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcript: fall Detroit and Seattle.   Okay.. our top story this week: XX The FDA approved Tzield for use in stage 3 T1D – that's what we used to just call type 1. It's the stage where the body can no longer produce enough insulin on its own to manage blood sugars you need to start insulin. This approval is for kids ages 8-17 within 8 weeks of a stage 3 T1D diagnosis. It comes after the PROTECT trial and it's the first approval of a disease-modifying therapy for stage 3 T1D. https://www.prnewswire.com/news-releases/breakthrough-t1d-celebrates-approval-of-tzield-for-use-in-stage-3-type-1-diabetes-in-the-us-302799532.html XX Encouraging results from a small study of islet cell transplantation in people with type 1 where now all 12 participants in the trial are currently living without external insulin after receiving transplanted insulin-producing islet cells.   The study, led by researchers at the University of Chicago, tested an experimental immune therapy called tegoprubart Te-GO-Proo-Bart. The drug is designed to prevent the body from rejecting transplanted cells while avoiding some of the side effects associated with standard anti-rejection medications. You've probably heard about this as the Eledon study – many of the participants have been very active on social media. It was presented at ADA. transplants.https://www.breakthrought1d.org/news-and-updates/tegoprubart-islet-transplant-all-participants-off-external-insulin/ XX New data suggest that acmopatide (ack-MOW-puh-tyd) (CT-868), an experimental once-daily dual GLP-1/GIP receptor agonist, may help people with type 1 diabetes improve blood sugar control, lose weight, and reduce insulin use. Across all doses, participants lost up to 7% of their body weight and reduced insulin use by as much as 15%. The study lasted just 16 weeks, so researchers say longer-term data will be needed to determine whether the benefits can be maintained and whether lower insulin requirements can be achieved without increasing the risk of hypoglycemia. XX A new combination therapy that pairs an amylin analog with semaglutide improved both blood sugar levels and weight loss in several groups of people with type 2 diabetes. The once-weekly injectable, known as CagriSema (KAG-ruh-SEM-uh), was evaluated in three Phase 3 REIMAGINE studies. In people early in the course of type 2 diabetes, researchers reported A1C reductions of up to 1.8 percentage points and significant weight loss compared to placebo after 40 weeks of treatment. Investigators also noted improvements in several cardiometabolic risk factors, including blood pressure. https://www.medpagetoday.com/meetingcoverage/ada/121658 XX Stelo for kids is now FDA cleared.. the over the counter Glucose Biosensor System is now approved for children as young as 2 years old who do not use insulin. The FDA identified pediatric prediabetes as a growing public health concern motivating the expanded indication, noting OTC CGMs can help younger users and their caregivers build glycemic awareness, track patterns in response to me https://www.hcplive.com/view/fda-clears-first-otc-glucose-monitor-for-children XX Insulet presented new data from its STRIVE and EVOLUTION 3 studies showing improved glucose control with its next-generation Omnipod 6. That's , the company's upcoming hybrid closed-loop system for people with type 1 and type 2 diabetes. The main difference between the Omnipod 6 and Insulet's current Omnipod 5 patch pumps is that the new system has a lower glucose target of 100 mg/dL and better Bluetooth connectivity Insulet also shared progress on a fully closed-loop system designed specifically for type 2 diabetes. It  does not require carb-counting or insulin bolusing ahead of meals. Physicians also don't need to program the starting settings.   XX Abbott shared new research highlighting challenges in identifying and managing diabetic ketoacidosis (DKA). The studies coincide with the company's development of Libre Duo, a dual glucose-ketone sensor that continuously tracks both measurements. Abbott reported that DKA can be difficult to recognize when patients first arrive at the hospital, based on data from more than 100,000 people. The company has submitted the dual sensor to the FDA and recently received CE Mark approval in Europe. More news from ADA including info from Dexcom, Sequel, Sensonics and the world loses a tireless T1D advocate.. that's all to come right after this. --   Back to the news.. XX   Dexcom announced its acquisition of Nutrisense, a company that combines continuous glucose monitoring with nutrition coaching and behavioral support. At ADA, the company also presented results from the CONNECT study showing significant A1C reductions and improved glucose control in people with type 2 diabetes not using insulin. The findings add to growing evidence supporting CGM use beyond intensive insulin therapy. We did an episode with CEO Jake Leach at ADA about these announcements as well as updates on G8, their hospital product and much more. XX Sequel Med Tech reported positive clinical results evaluating its twiist automated insulin delivery system in people with type 2 diabetes. The study showed improvements in A1C and time in range over 13 weeks XX Senseonics presented new real-world data supporting the performance of its Eversense 365 implantable CGM. The analysis included more than 12,000 sensors and demonstrated sustained accuracy and effectiveness in both open-loop and automated insulin delivery settings. Researchers also evaluated Eversense use with Sequel Med Tech's twiist system. The findings support broader use of long-term implantable CGM technology.   -- MiniMed used ADA 2026 to spotlight two recently cleared diabetes management systems. The MiniMed Flex pump offers a smaller, smartphone-controlled insulin pump option, while MiniMed Go combines the InPen smart insulin pen with Abbott's Instinct sensor. The products received FDA clearance earlier this year. XX Tandem Diabetes Care highlighted data supporting the use of its Control-IQ automated insulin delivery technology during pregnancy. Results from the CIRCUIT trial showed users spent approximately three additional hours per day in the recommended pregnancy glucose range compared with standard therapy. The findings helped support recent regulatory approvals for pregnancy use in both Europe and the United States. Tandem also expanded indications for adults with type 2 diabetes. XX Beta Bionics presented real-world data from the first three years of iLet Bionic Pancreas use. The company reported a 25% improvement in time in range among users, along with positive feedback from clinicians about simplified diabetes management. The iLet system requires only a user's weight to begin therapy and eliminates carbohydrate counting. Beta Bionics also highlighted growing access to near-real-time outcomes through its public data dashboard. XX MannKind presented new findings supporting its Afrezza inhaled insulin at ADA 2026. A post-hoc analysis of the INHALE-1 study found that pediatric users reported greater treatment satisfaction compared with those using rapid-acting injected insulin. The results come shortly after FDA approval expanded Afrezza's indication to include children. We did a bonus episode with one of the lead investigators of the study that lead to that approval. XX Adaptyx presented early clinical data supporting a wearable sensor that continuously measures cortisol levels. The device successfully tracked cortisol changes during both controlled testing and overnight monitoring in first-in-human studies. Company leaders say cortisol plays a major role in conditions including diabetes, hypertension, and depression. The technology uses synthetic DNA-based molecular switches to generate real-time readings.   XX Biolinq shared new clinical findings for its Shine continuous glucose monitoring system. The needle-free device combines glucose monitoring with activity and sleep tracking .The system received FDA clearance in 2025. They're also looking at measuring lactate through the sensor. XX Long-time T1D advocate Kent Schnakenberg died last week. Schnakenberg was known in his community for using his love of bicycling to raise awareness of Type 1 diabetes. He also advocated for improving the lives of those living with the disease. Inspired by his niece, Michelle, who was diagnosed with juvenile diabetes when she was 13 years old, since 2014 he has traveled around the country cycling thousands of miles, speaking to hundreds and hundreds of kids and raising Money. According to Schnakenberg's family, he suffered a head trauma incident in his home on Wednesday. I spoke to Kent years ago – I believe the first year of the podcast. A sad loss but wonderful to see so many tributes and memories posted on social media in the last few days. https://diabetes-connections.com/john-costik-co-creator-of-nightscout-team-schnak/ https://www.wibw.com/2026/06/12/team-schnak-founder-kent-schnakenberg-passes-away/ XX And finally. Alexander Zverev (ts-ver-uhv) won the French Open, his first Grand Slam title. He lives with type 1, he paused a couple of time to check his blood sugar. He was diagnosed at age 4 and partners with Medtronic. "Becoming a professional tennis player was always my dream," Zverev shared in an article posted by Medtronic. "Early on, I was told that competing at the highest level with diabetes was impossible — but my family and I refused to accept that. That's why I'm partnering with Medtronic Diabetes: I want every person with diabetes to feel empowered to live the life they want." He also has a foundation committed to children with type 1 diabetes. Among other things, the life-saving insulin and other essential drugs are provided – also in developing countries." https://www.mensjournal.com/news/alexander-zverev-diabetes-wins-french-open-2026-medical-condition

How do you protect the human craft of storytelling while navigating a global independent market that is rapidly contracting? This week, Giles Alderson and Phil Hawkins sit down for an incredibly candid, wide-ranging masterclass with Jonathan Yunger—President of Millennium Media and co-founder of Arcana Labs. Jonathan has masterminded massive worldwide features grossing billions of dollars—producing major franchise hits like The Expendables, The Hitman's Bodyguard, and the Fallen series, alongside star-driven indie standouts like Tesla starring Ethan Hawke, Jolt starring Kate Beckinsale, Till Death starring Megan Fox, and The Enforcer starring Antonio Banderas. His latest project, John Rambo (directed by Sisu filmmaker Jalmari Helander), is a masterclass in 99% practical, old-school action cinema. Yet, Jonathan is also leading the charge on ethical, artist-driven tech integration through Arcana Labs—an enterprise-grade ecosystem fully vetted by major streaming networks after rigorous multi-month security compliance reviews. In this episode, we strip away the PR spin to examine how the disruption of streaming windows broke the traditional indie minimum guarantee model, and why embracing assistive workflows is the key to reclaiming creative risk.

The Food and Drug Administration has approved a new active ingredient for sunscreens sold in the U.S. for the first time in nearly 30 years.

After 25 years, the FDA has approved bemotrizinol (BEMT) — the first new sunscreen filter in the U.S. since 1999 — and it could be a gamechanger for your SPF routine. The approval closes a real gap in UVA protection, with better coverage, better texture, and less irritation than what's currently on shelves. We also get into the TikTok Shop beauty rankings for May 2026, and the results are mindblowing: Medicube topped the charts at $19M, two of the top four brands are Korean, and Tarte is the only color cosmetics brand cracking the top three. Tune in to hear the entire list. Watch our episodes!Shop our episodesInstagram: @glossangelspod | TikTok: @glossangelespodEmail: glossangelespodcast@gmail.com Hosted on Acast. See acast.com/privacy for more information.

Next week, the skies of downtown will light up for the Detroit Fireworks ceremony, but for kids under 18, they will need a guardian to watch in person. WWJ's Tony Ortiz and Tracey McCaskill have the afternoon's top news stories.

Hey y'all! Join us as we discuss the My Hero Academia episode "Threads of Hope", including nice fancy rocks, gay twigs, and a highly speculative Science Corner about Best Jeanist's Quirk. Want more? Visit our website, myheroanalysis.com. Thanks for listening!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fight Genocide Worldwide Master Document⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Indivisible: A Practical Guide to Democracy on the Brink⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ACLU Know Your Rights⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bother Your Representatives

AM Best Director David Blades and Associate Analyst Dylan Catania discuss a new Best's Special Report that finds 2025 marked a significant shift back to pre-pandemic levels after years of large rate increases to keep up with elevated losses.

Donal O'Shea, endocrinologist and HSE Clinical Lead on Obesity

What happens when machines make life-and-death targeting decisions? Professor Mitt Regan joins TalksOnLaw to examine the law of autonomous weapons — how international humanitarian law applies to weapons that select and engage targets, and where human judgment must remain in the loop.How to Earn CLE CreditMCLE certificates are eligible only for TalksOnLaw Premium or Podcast members. To earn credit, listen to the full program, note the verification code announced during the recording, then log in to your TalksOnLaw account to record attendance and download your certificate at www.TalksOnLaw.com/podcast.Approved for 1 hr of general credit (Illinois) at the time of publication. Please visit TalksOnLaw to check whether older courses remain active for MCLE reporting purposes.

The founders of Lola Blankets, Will and Tommy Higham, share how they built their viral blanket brand from the bottom up following a very special, secret parting gift from their late mom. Despite having zero prior experience in the bedding industry, the brothers highlight everything from the trial-and-error science of creating their signature fabric to becoming the cozy luxury item that A-list celebrities swear by. They touch on staying fiercely loyal to their original mission: keeping things incredibly soft while donating blankets to breast cancer patients. Learn more about your ad choices. Visit podcastchoices.com/adchoices

You're Approved: A reminder that creatives don't need permission to pursue their ideas. Your voice, imagination, and unique perspective matter. Stop waiting for validation and start creating—the world needs what only you can bring.

WBBM political editor Geoff Buchholz updates the effort to legalize video gambling in the city of Chicago.

The criminal and civil cases surrounding Donald Trump have raised a range of professional responsibility questions — for prosecutors, defense counsel, and the lawyers who found themselves in the middle. Legal ethics professors Bruce Green and Rebecca Roiphe survey the ethical issues raised by the Trump trials and what they teach about the rules governing lawyers.How to Earn CLE CreditMCLE certificates are eligible only for TalksOnLaw Premium or Podcast members. To earn credit, listen to the full program, note the verification code announced during the recording, then log in to your TalksOnLaw account to record attendance and download your certificate at www.TalksOnLaw.com/podcast.Approved for 1.5 hrs of professional responsibility credit (Illinois) at the time of publication. Please visit TalksOnLaw to check whether older courses remain active for MCLE reporting purposes.

The Department of Justice just approved the Paramount and Warner Bros. Discovery deal, and it is the biggest media story of the week. In this quick hit episode of Geek Freaks Headlines, Frank breaks down what the $111 billion sign-off actually means, which regulators are still standing in the way, and why he believes this merger is bad news for fans, creators, and the entertainment industry as a whole.This is the largest federal hurdle the deal had to clear, and now that Washington has stepped aside, the conversation shifts to the state attorneys general and overseas regulators who could still slow it down. Frank also lays out exactly which franchises and brands would end up under the same corporate umbrella, from DC and Harry Potter to Star Trek and Top Gun, and makes the case for why all of that consolidation should worry you.0:00 DOJ Approves the $111 Billion Paramount and Warner Bros Deal0:16 The Studios and Franchises Being Combined0:25 Why Frank Thinks This Deal Should Be Stopped0:33 What Comes Next and Final ThoughtsThe DOJ has approved the Paramount and Warner Bros. Discovery deal valued at $111 billion, clearing the biggest federal antitrust hurdle the merger faced.The fight is not over. The California AG, New York, and nearly a dozen other states are still reviewing the deal, along with regulators in the UK and EU.Australia cleared the deal on June 9 and Germany cleared it earlier this year, so international approvals are starting to stack up.The combined company would unite DC, Harry Potter, Looney Tunes, and CNN with Paramount franchises like Star Trek, Top Gun, and Mission: Impossible.Frank's take is that this consolidation hampers creativity and leads to job losses, making it a win for the Ellisons and wealthy investors but a bad deal for everyone else."The DOJ just approved the Paramount and Warner Brothers deal for $111 billion. This clears the federal antitrust hurdle.""In my opinion, this deal has to be stopped. It will hamper creativity. It will be job losses.""This is a big win for them. As we get more information, I'll make sure to share it."For the full breakdown and all our latest coverage, head to GeekFreaksPodcast.com, your home for geek culture news.Follow us and join the conversation:Facebook: https://www.facebook.com/thegeekfreakspodcastThreads: https://www.threads.net/@geekfreakspodcastPatreon: https://www.patreon.com/GeekFreakspodcastWhere do you land on this one? Do you think the state AGs can actually stop the merger, or is this deal already a done deal? Send us your questions and hot takes and we may read them on a future episode.If you enjoyed this episode, subscribe wherever you get your podcasts, leave us a rating and review, and share it with a fellow geek using #Hollywood so more people can join the discussion.Paramount, Warner Bros, WBD merger, DOJ approval, Paramount Skydance, David Ellison, Hollywood mergers, antitrust, media consolidation, Star Trek, DC, Harry Potter, Top Gun, entertainment news, streaming wars, geek culture, film news, Geek Freaks HeadlinesTimestampsKey TakeawaysMemorable QuotesStay ConnectedJoin the ConversationSupport the Show

WBBM political editor Geoff Buchholz updates the effort to legalize video gambling in the city of Chicago.

When trying to get into an offer in compromise with the IRS, you want to put yourself in the best position possible. Is this possible if you are married filing separately? Find out in today's episode! If you owe the IRS at least $10,000 in back taxes or have multiple years of unfiled returns you need filed, book a free consultation here: https://choicetaxrelief.com/free-tax-...#OIC #offerincompromise #taxdebt

Virginia still doesn't have an approved budget. Why can't the Democrats agree on anything?

WBBM political editor Geoff Buchholz updates the effort to legalize video gambling in the city of Chicago.

Meet The Dubai Chef Approved By HH Sheikh Hamdan

The legal profession has long been defined as a high-performance environment characterized by competition and long hours. While dedication and hard work remain hallmarks of successful lawyers, there is a growing recognition of the tension between these professional demands and attorney mental health. Dean David Jaffe, Associate Dean for Student Affairs at American University, offers a unique perspective on this challenge, having co-piloted two national surveys on law student well-being.How to Earn CLE CreditMCLE certificates are eligible only for TalksOnLaw Premium or Podcast members. To earn credit, listen to the full program, note the verification code announced during the recording, then log in to your TalksOnLaw account to record attendance and download your certificate at www.TalksOnLaw.com/podcast.Approved for 1 hr of participatory California MCLE credit in the Competence (Prevention and Detection of Substance Abuse/Mental Health).

That's according to new figures released by the CSO this morning, our work and technology Correspondent Brian O'Donovan.

The legal profession has long been defined as a high-performance environment characterized by competition and long hours. While dedication and hard work remain hallmarks of successful lawyers, there is a growing recognition of the tension between these professional demands and attorney mental health. Dean David Jaffe, Associate Dean for Student Affairs at American University, offers a unique perspective on this challenge, having co-piloted two national surveys on law student well-being.How to Earn CLE CreditMCLE certificates are eligible only for TalksOnLaw Premium or Podcast members. To earn credit, listen to the full program, note the verification code announced during the recording, then log in to your TalksOnLaw account to record attendance and download your certificate at www.TalksOnLaw.com/podcast. Approved for 1 hr in the Mental Health/Substance Abuse category (professional responsibility) at the time of publication. Please visit TalksOnLaw to check whether older courses remain active for MCLE reporting purposes.

Why are some workplace truths unspeakable? This book summary reveals how to navigate office politics without saying a word you'll regret.

Discover what medical conditions qualify men for legal testosterone replacement therapy in Australia, the strict blood test thresholds required, and the compliant pathways to access doctor-supervised treatment—from GP referrals to telehealth options. Read more at https://trtaustralia.com/is-trt-legal-in-australia-status-treatment-options/ TRT Australia City: Hurstville Address: 7–11 The Avenue Website: https://trtaustralia.com/

The Minister for Food and Agriculture has not received GH¢200 million from the Ministry of Finance for buffer stock operations. Cabinet approved GH¢200 million for purchasing excess produce, but only GH¢100 million has been released. If the funds have been released, where are they? We demand clarity on the account the money was transferred into. - Samuel Huntor, Media Liaison Officer, Ministry of Food and Agriculture.

New treatment approved for adults with complicated urinary tract infections; Xocova approved for COVID-19 postexposure prophylaxis; investigational diabetic macular edema eye drop fails to meet trial endpoint; Afrezza expanded for pediatric use; obefazimod looks promising for ulcerative colitis.

On this bonus episode of Diabetes Connections.. a deep dive into inhaled insulin for kids. Last week the FDA approved Afrezza for kids six and older – it's been approved for adults for more than a decade – and boy did you have questions. We're talking to Dr. Jamie Wood, pediatric endocrinologist and  principal investigator of the INHALE-1 trial that helped lead to this approval. We're talking about what that studied showed, what the approval means, how to use Afrezza, and a bunch of your questions. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Our prevous episodes on Afrezza: https://diabetes-connections.com/?s=afrezza Our previous episode with Dr. Jamie Wood: https://diabetes-connections.com/top-ten-calls-your-endo-gets-in-the-middle-of-the-night/ Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com   

This is the All Local noon update for June 4. 2026.

House Bill 5024---awaiting to be signed by Governor Pritzker---restricts the location of newly created federal immigration detention centers in Illinois. Broadview Mayor Katrina Thompson says the bill will mean {quote}: "no Illinois community will be forced to absorb a detention facility in the shadow of its schools, its churches, or its homes". In January, Broadview adopted its own municipal ordinance restricting the location of new detention facilities within its borders.

See omnystudio.com/listener for privacy information.

House Bill 5024---awaiting to be signed by Governor Pritzker---restricts the location of newly created federal immigration detention centers in Illinois. Broadview Mayor Katrina Thompson says the bill will mean {quote}: "no Illinois community will be forced to absorb a detention facility in the shadow of its schools, its churches, or its homes". In January, Broadview adopted its own municipal ordinance restricting the location of new detention facilities within its borders.

It's in the News! The top diabetes stories and headlines happening now. Top stories this week include: Afrezza inhaled Insulin is Approved for Kids, CGM + Ketone Monitor gets European approval, Food Coloring & Diabetes Study, Device Recalls include Omnipod and Dexcom, Beta Bionics shares more about their patch pump, ADA conference info and more! This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcripts: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bring you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. ADA starts this week – safe travels to those of you heading to New Orleans. We'll be covering remotely so please follow on social – make sure to Like the FB page or join the group. We've got a wrap up episode planned for this podcast as well as some indepth interviews with the newsmakers from the conference. I will see some of you next week in Chicago. We have a couple of seats left for our Club 1921 dinner on June 10th in Northbrook – this is a FREE dinner for HCPs and patient leaders – all about screening for T1D. More info on the website under the events tab. Okay.. our top story this week: XX Afrezza inhaled insulin is now approved for kids and teens. The FDA okayed MannKind's afrezza for children 6 and older with type 1 and type 2 diabetes. MannKind says its proprietary Technosphere drug delivery platform enables the rapid absorption of insulin into systemic circulation. This follows FDA approval earlier this year for an update that revises recommendations for the starting mealtime dosage when patients switch from subcutaneous mealtime insulin regimens. MannKind also completed enrollment in February for a study evaluating the initiation of Afrezza therapy shortly after type 1 diabetes diagnosis in pediatric patients.   The company said it made Afrezza available for eligible patients for $35 or less per month. Desmond Schatz, professor of pediatrics at the University of Florida College of Medicine, said: "Mealtime insulin can be especially challenging for children because eating and snacking patterns, activity levels, and daily settings like school and sports often vary. With its rapid onset and dosing at the start of a meal, Afrezza may help clinicians better match insulin therapy to how children and families live day to day, while offering a needle-free mealtime option." Lots more to come on this – we're working on a bonus episode with one of the pediatric endos who worked on the clinical trials that led to this approval – hopefully have that out later this week. https://www.massdevice.com/mannkind-fda-approval-inhaled-insulin-children/ XX FDA has agreed to consider a new drug for the treatment of adults with type 1 and chronic kidney disease. Finerenone (fy-near-uh-known) is currently approved in the US for adults with CKD associated with type 2 diabetes and for adults with heart failure with left ventricular ejection fraction of 40% or greater. Chronic kidney disease (CKD) is present in over one-third of adults with diabetes, and because it's such a serious condition, interventions are needed to reduce its incidence and help people live a long and prosperous life. https://www.docwirenews.com/post/fda-grants-priority-review-to-finerenone-snda-for-type-1-diabetes-associated-ckd XX Abbot gets European approval for the world's first dual glucose‑ketone sensing technology for people with diabetes. They're calling this Libre Duo and Libre Duo 10 Day, and it's designed to continuously measure glucose and ketone levels every minute. Abbott plans to begin launching Libre Duo systems in select European countries later this year. Libre Duo delivers up to 15 days of wear and will be offered to adults ages 18 and older. Libre Duo 10 Day offers up to 10 days of wear and is intended for people ages 2 and older. Abbott is also working with leading pump companies to allow automated insulin delivery (AID) systems to connect with the sensors. https://abbott.mediaroom.com/2026-05-27-Abbott-secures-CE-Mark-for-worlds-first-dual-glucose-ketone-sensing-technology-for-people-with-diabetes   XX Huge recall for Omnipod. Insulin says a manufacturing issue through ongoing product monitoring that could result in insulin under-delivery  with specific lots of its Omnipod 5, Dash and Eros pods. Insulet said the scope of this action reaches approximately 7 million pods. This issue is separate from the March recall that affected certain Omnipod 5 lots. According to the Acton, Massachusetts-based company, some of its affected pods may have a small tear in the tubing (cannula) just above the skin. This tear lands between the pod and the point where the cannula enters the body. If this occurs, insulin may leak outside of the device instead of being fully delivered into the body as intended. This may lead to under-delivery of the therapeutic.   Individuals using an affected pod may notice wetness on the skin or pod adhesive or detect the smell of insulin. However, some cases may prove difficult to detect and go unnoticed. Of the approximately 7 million pods included in the action, approximately 60% have been consumed or are expired. The pods affected by the correction represent approximately 8.5% of the 2025 global Omnipod pod prodcution. Insulet says it has sufficient supply to replace affected pods. It expects no disruption to product availability. The company said it has notified the FDA and all other relevant regulatory authorities of its action.   The full list of affected pod lots can be found here. https://www.massdevice.com/insulet-another-omnipod-5-recall-dash-eros/ XX Dexcom is warning that certain scrapped glucose sensors have been stolen and resold. Dexcom said it has not received any reports of severe adverse events associated with the stolen product. One lot of scrapped devices carries a risk of infection for sensors that are not properly sterilized, and another lot had an elevated internal testing failure rate, meaning users would have an increased risk of having no sensor readings available. Dexcom said the affected sensors were stolen during the destruction process and then sold by third parties. The company routinely scraps sensors that do not meet its standards. The sensors are sent to a third-party vendor for destruction and recycling.   Dexcom said it traced sales of the stolen devices to Pharmsource, which is not an authorized Dexcom distributor but supplies some independent pharmacies and U.S. durable medical equipment distributors. Because of this, pharmacies that purchase products from Pharmsource should review their inventory, Dexcom said.   People with sensors from the affected lots should not use those sensors and can call customer support to request replacements. Dexcom has set up a website to help users check if their devices are affected. https://www.medtechdive.com/news/dexcom-warns-of-scrapped-glucose-sensors-being-resold/821139/ XX XX   Beta Bionics plans to debut its first insulin patch pump by the end of the second quarter of 2027, subject to Food and Drug Administration clearance. The device, called Mint, would be compatible with Beta Bionics' interoperable automated glycemic controller, a software that allows for the pump to automatically adjust insulin delivery based on readings from a glucose sensor. Beta Bionics first unveiled the prototype for Mint last year at the American Diabetes Association's Scientific Sessions. The device is expected to have a similar size and wear time, at three days, to Insulet's patch pumps on the market. It would have a 200-unit insulin reservoir.   Mint differs by containing a mix of reusable and disposable components. Beta Bionics plans to make the device exclusively available in the pharmacy channel, building on its existing agreements for its current iLet insulin pump. Beta Bionics is one of several diabetes tech companies developing patch pumps to compete with market leader Insulet. Tandem Diabetes Care and Medtronic spinoff MiniMed have also announced planned patch pumps. Tandem said it plans to file a 510(k) submission this quarter for a tubeless version of its small, durable pump, and Medtronic plans to submit its patch pump to the FDA this fall.   https://www.medtechdive.com/news/beta-bionics-to-launch-its-first-insulin-patch-pump-to-compete-with-insulet/821091/ XX CVS puts Zepbound back on it's coverage list – with it's Caremark PBM. They also added Foundayo, Lilly's obesity pill. CVS had dropped Lilly's Zepound last summer but kept competitor Wegovy. It'll be back at Caremark October first. All three of the nation's largest pharmacy ⁠benefit managers ​now cover Lilly's full obesity medicine portfolio. https://www.reuters.com/legal/litigation/cvs-brings-back-coverage-lillys-obesity-drug-zepbound-2026-05-28/   More to come, including a new benefit from metformin for women, something new from Tidepool, big news for T1D in Austalia and more.. XX A new study suggests that higher long-term exposure to food colouring additives — including both synthetic and natural colourings commonly found in processed foods and beverages — may be associated with an increased risk of developing type 2 diabetes. Researchers analyzed data from more than 108,000 adults in the French NutriNet-Santé cohort between 2009 and 2023, following participants for a median of just over eight years. During that time, 1,131 participants developed type 2 diabetes. The study found that people with the highest intake of total food colouring additives had a 38% higher risk of developing type 2 diabetes compared with non- or low-consumers.   Several specific additives were linked to increased risk, including caramel colouring additives such as total caramel (E150 family), plain caramel (E150a), sulphite ammonia caramel (E150d), and beta-carotene (E160a). Additional associations were observed for curcumin (E100), anthocyanins (E163), paprika extract (E160c), lutein (E161b), and cochineal-derived colourings (E120). "Our findings revealed positive associations between widely consumed food colouring additives and type 2 diabetes incidence," the authors wrote, adding that further research is needed to better understand the mechanisms behind the findings and whether food colouring regulations should be reevaluated. https://www.medscape.com/viewarticle/use-common-food-colours-tied-high-type-2-diabetes-risk-2026a1000hes XX Big news for Australia – their Therapeutic Goods Administration (TGA) approves Tzield. Tzield is now approved in Australia to delay the onset of stage 3 (or clinical) T1D in people aged eight years and older with stage 2 T1D – the early, pre-symptomatic stage of the condition, where changes in blood glucose levels have begun but insulin therapy is not yet required. Breakthrough T1D Australia Chief Executive Officer, Sydney Yovic, said the approval represented a transformational moment for Australians affected by T1D. https://newshub.medianet.com.au/2026/05/landmark-approval-of-tzield-in-australia-ushers-in-a-new-era-of-delay-for-type-1-diabetes/155036/ XX https://www.theatlantic.com/health/2026/05/diabetes-pregnancy/687324/ XX A common diabetes drug may hold great potential to help with aging, even if scientists aren't exactly sure why. According to a study, the drug metformin doesn't just help patients to effectively manage their type 2 diabetes. it may also give older women a better chance of living to 90. Scientists in the US and Germany used data from a long-term US study of postmenopausal women.   Records for a total of 438 people were selected – half of whom took metformin to treat diabetes, and half of whom took a different diabetes drug, sulfonylurea.   While there are some caveats and asterisks to the study, those in the metformin group were calculated to have a 30 percent lower risk of dying before the age of 90 than those in the sulfonylurea group. The study used age 90 as the marker for 'exceptional' longevity. However, scientists aren't yet sure that the drug extends lifespan, especially in humans – which is part of the reason for this study. RCTs could follow further down the line to dig deeper into these results, the researchers suggest. In the meantime, as the global population continues to skew older, studies continue to find ways to keep us healthier for longer and reduce damage to the body as we age. https://www.sciencealert.com/a-common-diabetes-drug-is-linked-with-exceptional-longevity-in-women XX The American Diabetes Association® (ADA) will host the 2026 Scientific Sessions from June 5-8 in New Orleans. The ADA's Scientific Sessions is the world's largest diabetes meeting, convening an expected audience of over 12,000 leading physicians, scientists, researchers, and healthcare professionals from around the globe. The premier diabetes meeting, which is also offered virtually, will feature the latest scientific findings in diabetes and obesity, where leading experts and peers will share findings in research for prevention, care, and cures at the Ernest N. Morial Convention Center. Key themes will include: Advancing obesity and metabolic health: Prevention, early detection, and disease modification: Improving cardiometabolic outcomes: Transforming care through innovation and access: New research will highlight how technology, artificial intelligence, and implementation strategies are reshaping diabetes care—reducing treatment burden, expanding access, and enabling more person-centered care. Advancing beta cell replacement and cure strategies: Fostering innovation: On Saturday, June 6, from 4:30-6:00 p.m., the Innovation Challenge, which debuted in 2023, invites emerging companies to pitch novel ideas to improve the lives of people living with diabetes. A panel of judges, with input from a live audience, determines which contestants will earn a private audience with potential funders. XX Tidepool, the nonprofit leader advancing innovation in diabetes technology, announced that Tidepool+ Direct Connect is now available through the Epic Showroom. Built on SMART on FHIR, Direct Connect brings interactive diabetes device data directly into Epic workflows, helping clinicians use patient data during routine care. "Tidepool has always focused on making diabetes data more accessible and actionable," said Brandon Arbiter, CEO. "We're excited to empower clinicians using Epic with insightful, intuitive patient data that fits directly into their encounter workflow so they can use it to improve care in the moment it matters."   Tidepool+ Direct Connect supports scalable deployment across Epic-enabled health systems. This architecture enables faster, more intuitive rollouts, enhancing Tidepool's existing EHR integration capabilities.   Direct Connect is part of Tidepool's ongoing work to improve how clinicians can use timely and relevant diabetes device data during patient visits to help drive better health outcomes.   The feature is now available in the Connection Hub of the Epic Showroom.   https://www.businesswire.com/news/home/20260527780274/en/Tidepool-Launches-in-Epic-Showroom-to-Bring-Diabetes-Device-Data-into-the-Point-of-Care XX

Southwest Michigan's Morning News podcast is prepared and delivered by the WSJM Newsroom. For these stories and more, visit https://www.wsjm.com and follow us for updates on Facebook. See omnystudio.com/listener for privacy information.

In the final hour, Leila Rahimi, Marshall Harris and Mark Grote reacted to Chicago mayor Brandon Johnson's recent comments as he continues to make a last-ditch attempt to keep the Bears in the city. Later, they took calls from Score listeners who sounded off on the Bears' stadium pursuit hitting yet another roadblock.

Covers the NBA for the Athletic Tony Jones

What a nice surprise that Sandra got from her son last week. For a belated Mother's Day meal, Sam made an incredible salad (with many of the ingredients added that he used to hate to eat as a kid!).What ingredients made it so delicious and why was it so healthy?Tune in to hear this delicious, unconventional combination of foods that turned Sandra's dinner salad into a memorable meal.Episodes mentioned included:Nutrition Nuggets 54. How to Make Your Salad A Mealhttps://youtu.be/36oR2ltOuy0?si=neXbf3-BzkTrmoyNNutrition Nuggets 134. Dense Bean Salad Recipehttps://youtu.be/RgtIwlW6SgY?si=FjQbdDdB6fYKlqFPNutrition Nuggets 72. Why Are Greens So Important?https://youtu.be/Hio4uTJsi8E?si=0ibtEd-PRjfPjY6pNutrition Nuggets 128. Why You Need To Eat A Variety of Veggieshttps://youtu.be/Kb9qD9ly1fA?si=HKTqsPgc8PmCusakNutrition Nuggets 118. Fibre and Protein Lunch Ideashttps://youtu.be/gywh7fG0hm4?si=1xTlKpc8HW-PbXYmEnjoying the show? Consider leaving a 5 star review, and/or sharing this episode with your friends and family :)Sign up for our ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠newsletter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on our website for weekly updates and other fun info. You can also visit our social media pages. We're on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Your support helps fuel the stoke and keeps the show going strong every week. Thanks!Website: www.mywifethedietitian.comEmail: mywifetherd@gmail.com

Headlines: – Welcome to Mo News + AI Puerto Rico Song Going Viral (02:00) – Iran War: Trump Says Political Pressure Will Not Sway Him in Talks (07:00) – Trump: Middle Eastern Countries 'Owe It to Us' to Join Abraham Accords (10:40) – Israel Issues New Evacuation Warnings For Southern Lebanon  (13:00) – Iran's Internet Is Partially Restored (14:15) – Where In The World Is Missing N.J. Congressman? (15:45) – U.S. To Set Up Quarantine Facility in Kenya for Americans Exposed to Ebola (23:00) – Why Americans Are About to Pay Even More at the Grocery Store (26:50) – DHS Sec. Reveals Plan To Potentially Limit International Travel At Some Major West Coast Airports (29:40) – Experts Just Added A Blood Test To Colon Cancer Screening Options, As Many Skip Colonoscopies (31:50) – Trump Says He May Attend Knicks' NBA Finals Game In New York (34:00) – On This Day In History (38:40) Thanks To Our Sponsors: – ⁠Monarch⁠ - 50% off your first year | Code: MONEWS – ⁠Factor⁠ - 50% off your first box | Code: monews50off – Industrious⁠⁠ - Coworking office. 50% off day pass | Code: MONEWS50 – ⁠LMNT⁠ - Free Sample Pack with any LMNT drink mix or 12oz cans purchase

The Luigi Mangione case update takes another shocking turn as the judge approves key pieces of evidence while public fascination around the accused CEO killer continues to grow online. In this episode of the STS podcast, we break down the latest developments in the Luigi Mangione case update, including the evidence now allowed in court, the growing media frenzy, and the disturbing social media attention surrounding the case. The Luigi Mangione case update is quickly becoming one of the biggest stories in true crime news. We take a closer look at what prosecutors may use at trial, why the approved evidence could be critical, and how online reactions are shaping public perception of the accused. This episode also explores the darker side of internet fame and how high-profile criminal cases can attract intense attention online. As more details emerge, this story connects to broader real crime stories, unresolved cold cases, and emotional survivor stories that highlight the devastating impact violent crimes have on victims, families, and communities. If you're following this developing case, this episode delivers a direct and concise breakdown of the latest courtroom developments and what could happen next.Key Points from the Episode: Breakdown of the Luigi Mangione case update Judge approves important evidence for trial Public and social media reaction to the case Discussion of online obsession surrounding accused killers What the new evidence could mean moving forward If you or someone you know experienced serious mental health struggles as a result of social media use, you may be entitled to a potential recovery of over $1,000. Visit https://morganmorganpa.sjv.io/c/72737... to submit a claim now. In this STS episode, Host Joel Waldman dives in to the latest court hearings, the freaky fan girls and why they're standing up for Luigi Mangione and the evidence that could make or break Luigi Mangione's case. Will he be freed...or will he be convicted for the murder of healthcare CEO Brian Thompson? Support the show & be a part of #STSNation: Donate to STS' Trial Travel: Https://www.paypal.com/ncp/payment/GJ... VENMO: @STSPodcast or Https://www.venmo.com/stspodcast Check out STS Merch: Https://www.bonfire.com/store/sts-store/ Joel's Book: Https://amzn.to/48GwbLx Support the show on Patreon: https://www.patreon.com/SurvivingTheSurvivor Email: SurvivingTheSurvivor@gmail.com   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Chris sits down with John McQueeney, State Representative for House District 97 in Tarrant County, Texas and member of the State Affairs Committee covering power grid and electric policy. In the last six weeks alone, John's committee has run three interim data center hearings. He is also drafting the Data Center Responsibility Act for the January 2027 session - the bill that will set the framework for how Texas handles the data center build-out for a generation. Texas has 440 gigawatts of applications in the queue against roughly 110 gigawatts of current peak capacity. Someone has to sort out what's real, what's speculative, and who pays for the grid when it all comes online. John is one of the people doing that work. They discuss: Why the data center industry is losing a PR battle it should be winning The tax story hyperscalers haven't been telling How the large load approval process works in Texas, end to end - from TSP submission to ERCOT study to Approved to Energize What's real vs. speculative in the 440 GW pipeline Behind-the-meter data centers as grid stabilizers What the Data Center Responsibility Act will cover The railroad analogy: why communities that miss this build-out will fall behind for decades Timestamps:(00:00) Intro(02:27) Why Data Centers Are a "12 Out of 10" for Texas(08:17) A Day Without a Data Center(09:34) Inside Stargate: Lancium, Crusoe, Oracle & OpenAI(14:34) When One Data Center Funds 30% of a City's Budget(17:03) The Vicious Restudy Cycle & the Batch Zero Fix(28:55) 440 GW of Applications Chasing 105 GW of Capacity(35:53) The 75 MW Threshold & Going Behind the Meter(48:36) Drafting the Data Center Responsibility Act(54:19) North Texas's Hidden Risk in Batch Zero(01:08:35) Who Actually Pays for the Grid Buildout?(01:14:32) Data Centers Are a National Security Issue(01:18:12) Data Centers in Space & the Long Arc ----- Presented by Airshare: Trusted across the country for fractional ownership, jet cards, charter, and aircraft management, Airshare gives you a smarter way to fly private - over 25 years of experience, operating their own fleet, with the top safety ratings in the industry. Drive up to the FBO, walk on, and go. Go to flyairshare.com to learn more. ----- Sponsored by Collateral Partners: Collateral Partners builds institutional-grade investor materials for private credit, private equity, real estate, and family office firms - the kind of marketing collateral that helps you close capital. Learn more at collateral.com/fort. ----- Chris on Social Media: X: https://x.com/fortworthchris Instagram: https://www.instagram.com/thepowerspodcast LinkedIn: https://www.linkedin.com/in/chrispowersjr/ Visit our website: https://www.powerspod.com/Leave a review on Apple: https://bit.ly/45crFD0Leave a review on Spotify: https://bit.ly/3Krl9jO

Rick Stroud and Steve Versnick on the Rays MOU being approved by the Tampa City Council by a close 4-3 vote. There is still work to be done before a final deal can be reached. Plus the Rays have a big series against the Yankees this weekend as they enter 4.5 games ahead of New York. Hosted on Acast. See acast.com/privacy for more information.